Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (73)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Skerra, A.
Right arrow Articles by Plückthun, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skerra, A.
Right arrow Articles by Plückthun, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Protein Engineering vol. 4 no. 8 pp. 971-979, 1991
© 1991 Oxford University Press


RESEARCH-ARTICLE

Secretion and in vivo folding of the Fab fragment of the antibody McPC603 in Escherichia coli: influence of disulphides and cis-prolines

Arne Skerra1 and Andreas Plückthun2

Genzentrum der Universität München, Max-Planck-Institut für Biochemie Am Klopferspitz, D-8033 Martinsried, Germany 1Present address: Max-Planck-Institut für Biophysik, Abt. Molekulare Membranbiologie Heinrich-Hoffmann-Strasse 7, 6000 Frankfurt 71, Germany

2To whom correspondence should be addressed

Using the well-characterized antibody McPC603 as a model, we had found that the Fv fragment can be isolated from Escherichia coli as a functional protein in good yields, whereas the amount of the correctly folded Fab fragment of the same antibody produced under identical conditions is significantly lower. In this paper, we analyse the reasons for this difference. We found that a variety of signal sequences function in the secretion of the isolated chains of the Fab fragment or in the co-secretion of both chains in E.coli. The low yield of functional Fab fragment is not caused by inefficient expression or secretion in E.coli, but by inefficient folding and/or assembly in the periplasm. We compared the folding yields for the Fv and the Fab fragment in the periplasm under various conditions. Several diagnostic framework variants were constructed and their folding yields measured. The results show that substitutions affecting cis-proline residues and those affecting various disulphide bonds in the protein are by themselves insufficient to dramatically change the partitioning of the folding pathway to the native structure, and the cause must lie in a facile aggregation of folding intermediates common to all structural variants. However, all structural variants could be obtained in native form, demonstrating the general utility of the secretory expression strategy.

Keywords: antibody/expression in E.coli/protein folding/protein secretion

Received May 20, 1991; accepted October 3, 1991.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Protein Eng Des SelHome page
M. Schlapschy, S. Grimm, and A. Skerra
A system for concomitant overexpression of four periplasmic folding catalysts to improve secretory protein production in Escherichia coli
Protein Eng. Des. Sel., August 1, 2006; 19(8): 385 - 390.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
P. Belin, J. Dassa, P. Drevet, E. Lajeunesse, A. Savatier, J.-C. Boulain, and A. Menez
Toxicity-based selection of Escherichia coli mutants for functional recombinant protein production: application to an antibody fragment
Protein Eng. Des. Sel., May 1, 2004; 17(5): 491 - 500.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Rauchenberger, E. Borges, E. Thomassen-Wolf, E. Rom, R. Adar, Y. Yaniv, M. Malka, I. Chumakov, S. Kotzer, D. Resnitzky, et al.
Human Combinatorial Fab Library Yielding Specific and Functional Antibodies against the Human Fibroblast Growth Factor Receptor 3
J. Biol. Chem., October 3, 2003; 278(40): 38194 - 38205.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. V. Kolesnikov, A. V. Kozyr, E. S. Alexandrova, F. Koralewski, A. V. Demin, M. I. Titov, B. Avalle, A. Tramontano, S. Paul, D. Thomas, et al.
Enzyme mimicry by the antiidiotypic antibody approach
PNAS, November 22, 2000; (2000) 200360497.
[Abstract] [Full Text]


Home page
Appl. Environ. Microbiol.Home page
J. F. Rippmann, M. Klein, C. Hoischen, B. Brocks, W. J. Rettig, J. Gumpert, K. Pfizenmaier, R. Mattes, and D. Moosmayer
Procaryotic Expression of Single-Chain Variable-Fragment (scFv) Antibodies: Secretion in L-Form Cells of Proteus mirabilis Leads to Active Product and Overcomes the Limitations of Periplasmic Expression in Escherichia coli
Appl. Envir. Microbiol., December 1, 1998; 64(12): 4862 - 4869.
[Abstract] [Full Text]


Home page
CVIHome page
H. J. W. de Haard, B. Kazemier, M. J. M. Koolen, L. J. Nijholt, R. H. Meloen, B. van Gemen, H. R. Hoogenboom, and J.-W. Arends
Selection of Recombinant, Library-Derived Antibody Fragments against p24 for Human Immunodeficiency Virus Type 1 Diagnostics
Clin. Vaccine Immunol., September 1, 1998; 5(5): 636 - 644.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
G. Forsberg, M. Forsgren, M. Jaki, M. Norin, C. Sterky, A. Enhorning, K. Larsson, M. Ericsson, and P. Bjork
Identification of Framework Residues in a Secreted Recombinant Antibody Fragment That Control Production Level and Localization in Escherichia coli
J. Biol. Chem., May 9, 1997; 272(19): 12430 - 12436.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Bothmann and A. Pluckthun
The Periplasmic Escherichia coli Peptidylprolyl cis,trans-Isomerase FkpA. I. INCREASED FUNCTIONAL EXPRESSION OF ANTIBODY FRAGMENTS WITH AND WITHOUT cis-PROLINES
J. Biol. Chem., May 26, 2000; 275(22): 17100 - 17105.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. V. Kolesnikov, A. V. Kozyr, E. S. Alexandrova, F. Koralewski, A. V. Demin, M. I. Titov, B. Avalle, A. Tramontano, S. Paul, D. Thomas, et al.
Enzyme mimicry by the antiidiotypic antibody approach
PNAS, December 5, 2000; 97(25): 13526 - 13531.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.